Eligo Bioscience raised €17M in a Series A round in Sep 2017. The company is based in France. Investors in the round: Khosla Ventures, Seventure Partners. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
